Amendment114th Congress
An amendment numbered 7 printed in House Report 114-193 to direct the Food and Drug Administration to issue a report on the risks and benefits associated with a two-tiered approval process that would permit certain medical devices to provisionally come to market if they have demonstrated safety but not efficacy.
- Amendment Number
- 662
- Description
- An amendment numbered 7 printed in House Report 114-193 to direct the Food and Drug Administration to issue a report on the risks and benefits associated with a two-tiered approval process that would permit certain medical devices to provisionally come to market if they have demonstrated safety but not efficacy.
- Purpose
- An amendment numbered 7 printed in House Report 114-193 to direct the Food and Drug Administration to issue a report on the risks and benefits associated with a two-tiered approval process that would permit certain medical devices to provisionally come to market if they have demonstrated safety but not efficacy.
- Congress
- 114
- Type
- HAMDT
- Latest Action Date
- Jul 10, 2015
- Latest Action Text
- By unanimous consent, the Polis amendment was withdrawn. (consideration: CR H5078)
- Latest Action Time
- 10:27:00
- Submitted Date
- Jul 10, 2015
- Chamber
- House of Representatives
- Update Date
- Dec 15, 2020